Role of Steroids in Tubercular Pleural Effusio
Phase 3
- Conditions
- Health Condition 1: A156- Tuberculous pleurisy
- Registration Number
- CTRI/2020/10/028513
- Lead Sponsor
- Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Patient having moderate to massive pleural effusion.
2) Those who give inform consent for study.
Exclusion Criteria
1) Patient shifted to institute ICU.
2) Consent not given by patient or legal attendant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time of resolution of <br/ ><br>pleural effusion. <br/ ><br> <br/ ><br>Timepoint: 15 days and 30 days <br/ ><br>
- Secondary Outcome Measures
Name Time Method Presence or absence of pleural thickeningTimepoint: 15 days and 30 days